World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
53
Citations
8428
World Ranking
2398
National Ranking
187

Ailong Huang publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ailong Huang sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 249 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Ailong Huang D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ailong Huang sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 53 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Ailong Huang is affiliated with the MRC Laboratory of Molecular Biology in the United Kingdom. Their research spans key areas within medicine and biochemistry, genetics, and molecular biology, with a focus on infectious diseases, molecular biology, and epidemiology. Specific subfields include cancer research and hepatology.

The primary topics of their scientific work concentrate largely on viral and immunological studies, particularly those related to SARS-CoV-2 and COVID-19. Research themes encompass COVID-19 clinical studies, hepatitis B and C virus investigations, as well as SARS-CoV-2 detection, testing, and the long-term effects of COVID-19. The recurrent emphasis on viral pathology and immune responses is reflected in their publication record.

Frequent collaborators in Huang's scholarly output include Ni Tang, Kai Wang, Haijun Deng, Quanxin Long, and Juan Chen. These coauthors have contributed extensively to joint research efforts, indicating sustained collaborative networks in related topics.

Most publications appear in venues known for disseminating biomedical and virology research. Huang has regularly published in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Genes & Diseases
  • Signal Transduction and Targeted Therapy
  • Journal of Medical Virology
  • Nature Communications

Representative recent papers authored by Huang include:

  • "Antibody responses to SARS-CoV-2 in patients with COVID-19," 2020, Nature Medicine
  • "Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections," 2020, Nature Medicine
  • "Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications," 2021, Nature Communications
  • "GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis," 2021, Cell Death and Disease
  • "Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection," 2020, Clinical Infectious Diseases

Best Publications

  • Antibody responses to SARS-CoV-2 in patients with COVID-19.

    Quan Xin Long;Bai Zhong Liu;Hai Jun Deng;Gui Cheng Wu

  • Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

    Quan Xin Long;Xiao Jun Tang;Qiu Lin Shi;Qin Li

  • Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.

    Xin Xu;Jian Sun;Sheng Nie;Huiyuan Li

  • SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase‐3β/β‐catenin signaling

    Juan Chen;Anthony W.H. Chan;Ka-Fai To;Weixian Chen

  • Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.

    Nan Xiao;Meng Nie;Huanhuan Pang;Bohong Wang

  • Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

    Kai Wang;Quan-Xin Long;Hai-Jun Deng;Jie Hu

  • Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth

    Juan Chen;Bin Zhang;Nathalie Wong;Anthony W.I. Lo

  • GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis

    Qiujie Wang;Cheng Bin;Qiang Xue;Qingzhu Gao

  • A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.

    Xue-Fei Cai;Juan Chen;Jie Li Hu;Quan-Xin Long

  • D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

    Hu J;He C;Gao Q;Zhang G

  • The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera

    Jie Hu;Chang Long He;Qingzhu Gao;Gui Ji Zhang

  • MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B.

    Hongyan Guo;Haiying Liu;Keith Mitchelson;Huiying Rao

  • Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.

    Jiao Liu;Xiong Ding;Jia Tang;Youde Cao

  • Sirtuin 1 Regulates Hepatitis B Virus Transcription and Replication by Targeting Transcription Factor AP-1

    Ji-Hua Ren;Ying Tao;Zhen-Zhen Zhang;Wei-Xian Chen

  • Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice

    Quan-xin Long;Hai-jun Deng;Hai-jun Deng;Juan Chen;Jieli Hu

  • Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors

    Jiaming Fan;Qiang Wei;Junyi Liao;Junyi Liao;Yulong Zou;Yulong Zou

  • Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression

    Shaoying Yan;Zhenrong Tang;Ke Chen;Yuyang Liu

  • SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.

    Long-Kuan Ran;Yong Chen;Zhen-Zhen Zhang;Na-Na Tao

  • Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.

    Qing Xie;Linlin Chen;Xuefeng Shan;Xiaoliang Shan

  • GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis

    Qiujie Wang;Bin Cheng;Qiang Xue;Qingzhu Gao

Frequent Co-Authors

Tong-Chuan He
Tong-Chuan He University of Chicago
Hue H. Luu
Hue H. Luu University of Chicago
Rex C. Haydon
Rex C. Haydon University of Chicago
Zhenghong Yuan
Zhenghong Yuan Fudan University
Wei Xu
Wei Xu Fudan University
Mengji Lu
Mengji Lu University of Duisburg-Essen
Qian Tao
Qian Tao Chinese University of Hong Kong
Yang Bi
Yang Bi Chongqing Medical University
Paul B.S. Lai
Paul B.S. Lai Chinese University of Hong Kong
Ka-Fai To
Ka-Fai To Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology opens doors to a variety of careers beyond traditional lab research. Many related fields now offer flexible online degrees, making it easier to specialize or change career paths. For instance, if you are interested in the counseling side of healthcare, consider exploring online masters degrees in counseling, which can prepare you for mental health support roles.

Those looking to bridge biology with psychology may find online clinical psychology programs a good fit. These programs can lead to careers in therapy, assessment, or clinical research. For students wanting a shorter, entry-level route into social services, there are human services online degree options, ideal for roles in community organizations and health services.

Additionally, a background in molecular biology can be valuable for those interested in speech pathology. Learn more about the education required to be a speech pathologist and how this career supports individuals with communication and swallowing disorders. These online degrees enable flexible learning while supporting diverse career transitions in science and healthcare.

Best Scientists Citing Ailong Huang

Trending Scientists